English Alias: |
(R)-2-Amino-2-(4-hydroxyphenyl)acetic acid;D-(-)-4-Hydroxyphenylglycine;(R)-(-)-alpha-Amino-(4-hydroxyphenyl)acetic acid;H-D-Phg(4-OH)-OH;2-(4-Hydroxy-phenyl)glycin D-Form;4-HYDROXY-D-PHENYLGLYCINE;PH Dane-acid;D-4-Hydroxyphenylglycine;D(-)4-P-hydroxyphenylglycine;D(-)-4-Hydroxyphenylglycine;4-Hydroxy-D-(-)-2-phenylglycine;(αR)-α-Amino-4-hydroxybenzeneacetic acid;(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid;L-(-)-4-Hydroxy-α-aminophenylacetic acid;(2R)-2-Amino-2-(4;(2R)-2-Amino-2-(4-hydroxyphenyl)acetic acid,4-Hydroxy-D-phenylglycine,Cefadroxyl impurity A;(R)-2-(4-Hydroxyphenyl)glycine;(R)-para-hydroxyphenylglycine;D-(-)-2-(4-Hydr;D(-)-2-(4-hydroxyphenyl)glycine;D-N-(4-Hydroxyphenyl)glycine;D-α-(4-Hydroxy-phenyl)glycine;Cefadroxyl impurity A;(R)-(-)-2-Amino-2-(4-hydroxyphenyl)acetic Acid;D-(-)-2-(4-Hydroxyphenyl)glycine;D-2-(4-Hydroxyphenyl)glycine;D-p-Hydroxyphenylglycine;(R)-alpha-Amino-4-hydroxybenzeneacetic acid;Canagliflozin Impurity 21;PCM9OIX717;(2R)-amino(4-hydroxyphenyl)acetic acid;Benzeneacetic acid, a-amino-4-hydroxy-, (aR)-;(R)-2;Cefprozil Impurity A;Cefprozil Impurity;AS-12542;Z1198149764;(R)-(4-Hydroxyphenyl)glycine; (R)-2-(4-Hydroxyphenyl)glycine; 4-Hydroxy-D-phenylglycine; D-(-)-2-(4-Hydroxyphenyl)glycine; D-(-)-2-(p-Hydroxyphenyl)glycine;AMOXICILLIN TRIHYDRATE IMPURITY I [EP IMPURITY];D-(-)-.ALPHA.-(4-HYDROXYPHENYL)GLYCINE;A816374;p-hydroxy-D-phenylglycine;EINECS 245-247-7;CEFPROZIL MONOHYDRATE IMPURITY A [EP IMPURITY];DTXSID401014840;D-(-)-.ALPHA.-AMINO-4-HYDROXYPHENYLACETIC ACID;Q27095129;(.ALPHA.R)-.ALPHA.-AMINO-4-HYDROXYBENZENEACETIC ACID;A-Amino-4-hydroxybenzeneacetic acid;EN300-105272;CHEBI:15695;LJCWONGJFPCTTL-SSDOTTSWSA-N;SCHEMBL124861;D-alpha-(4-hydroxyphenyl)glycine;GLYCINE, 2-(P-HYDROXYPHENYL)-, D-;AC-1085;H0758;(;Epitope ID:117718;22818-40-2;D-(-)-amino(4-hydroxyphenyl)acetic acid;HY-34588;(R)--Amino-4-hydroxybenzeneacetic acid;D-(-)-2-(P-HYDROXYPHENYL)GLYCINE;(alphaR)-alpha-Amino-4-hydroxybenzeneacetic acid;DB04308;CEFADROXIL MONOHYDRATE IMPURITY A [EP IMPURITY];UNII-PCM9OIX717;Benzeneacetic acid, .alpha.-amino-4-hydroxy-, (.alpha.R)-;d-4-hydroxyphenylglicyne;(2R)-2-azaniumyl-2-(4-hydroxyphenyl)acetate;(R)-2-Amino-2-(4-hydroxyphenyl)acetic Acid;AKOS006281607;D-?-(4-hydroxyphenyl)glycine;D-.ALPHA.-P-HYDROXYPHENYLGLYCINE;CEFADROXIL IMPURITY A [EP IMPURITY];(R)-Ethyl 2-amino-2-(4-hydroxyphenyl)acetate;(2R)-amino(4-hydroxyphenyl)ethanoic acid;D-(-)-p-Hydroxyphenylglycine;NS00005440;4-Hydroxyphenylglycine, D-(-)-;CEFPROZIL IMPURITY A [EP IMPURITY];4-Hydroxy-D-phenylglycine, >=98%;AR)-;D-.ALPHA.-AMINO-4-HYDROXYPHENYLACETIC ACID;MFCD00004262;P-hydroxy-(R)-phenylglycine;AMOXICILLIN IMPURITY I [EP IMPURITY];Cefprozil impurity A, European Pharmacopoeia (EP) Reference Standard;C03493;EC 245-247-7;D-alpha-(4-Hydroxy-phenyl)glycine, European Pharmacopoeia (EP) Reference Standard;CS-0020117;D-2-amino-2-(p-hydroxyp... |